APA (7th ed.) Citation

Alkaff, F. F., Lammerts, R. G. M., Tiller, G., Heuvel, M. C. v. d., Bajema, I. M., Daha, M. R., . . . Berger, S. P. (2025). Alternative pathway–mediated tubular complement activation in human proteinuric kidney diseases: A proof-of-concept study. Clinical Kidney Journal, 18(11), 1. https://doi.org/10.1093/ckj/sfaf320

Chicago Style (17th ed.) Citation

Alkaff, Firas F., Rosa G M. Lammerts, Gesa Tiller, Marius C van den Heuvel, Ingeborg M. Bajema, Mohamed R. Daha, Jacob van den Born, and Stefan P. Berger. "Alternative Pathway–mediated Tubular Complement Activation in Human Proteinuric Kidney Diseases: A Proof-of-concept Study." Clinical Kidney Journal 18, no. 11 (2025): 1. https://doi.org/10.1093/ckj/sfaf320.

MLA (9th ed.) Citation

Alkaff, Firas F., et al. "Alternative Pathway–mediated Tubular Complement Activation in Human Proteinuric Kidney Diseases: A Proof-of-concept Study." Clinical Kidney Journal, vol. 18, no. 11, 2025, p. 1, https://doi.org/10.1093/ckj/sfaf320.